Media center

Press release
Owkin launches ATLANTIS: An extensive multimodal patient data discovery program across 7 countries in 11 therapeutic areas

February 27, 2025
Press release
Owkin launches ATLANTIS: An extensive multimodal patient data discovery program across 7 countries in 11 therapeutic areas

February 27, 2025
Press release
Aster Insights and Owkin collaborate to accelerate research in breast cancer
April 12, 2024
Press release
Jean-Jacques Bienaimé appointed Chairman of the Board at Owkin
March 25, 2024
Press release
Owkin expands collaboration with Sanofi to apply AI for drug positioning in immunology
March 21, 2024
Press release
Aster Insights and Owkin collaborate to accelerate research in breast cancer
April 12, 2024
Press release
Jean-Jacques Bienaimé appointed Chairman of the Board at Owkin
March 25, 2024
Access our Press Kit

Explore

Newest / Oldest
Select
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Press release
Owkin launches ATLANTIS: An extensive multimodal patient data discovery program across 7 countries in 11 therapeutic areas
February 27, 2025
Button
Owkin launches ATLANTIS: An extensive multimodal patient data discovery program across 7 countries in 11 therapeutic areas
February 27, 2025
Button
In the media
EY features Owkin's CEO Thomas Clozel in the "Grow Fast, Now What?" podcast (FR)
February 18, 2025
Button
EY features Owkin's CEO Thomas Clozel in the "Grow Fast, Now What?" podcast (FR)
February 18, 2025
EY
Button
In the media
Wall Street Journal features CEO Thomas Clozel
February 10, 2025
Button
Wall Street Journal features CEO Thomas Clozel
February 10, 2025
WSJ
Button
In the media
Les Echos covers Owkin’s role in AI in healthcare for the AI Action Summit
February 9, 2025
Button
Les Echos covers Owkin’s role in AI in healthcare for the AI Action Summit
February 9, 2025
Les Echos
Button
In the media
Owkin’s CEO, Thomas Clozel named in Le Figaro’s top 7 french leaders in AI
February 6, 2025
Button
Owkin’s CEO, Thomas Clozel named in Le Figaro’s top 7 french leaders in AI
February 6, 2025
Le Figaro
Button
In the media
France 24 covers Owkin’s Glioblastoma AI Hackathon
February 4, 2025
Button
France 24 covers Owkin’s Glioblastoma AI Hackathon
February 4, 2025
France 24
Button
In the media
STAT interviews Owkin SVP Andrew Pierce about OKN4395
January 30, 2025
Button
STAT interviews Owkin SVP Andrew Pierce about OKN4395
January 30, 2025
STAT
Button
Press release
Owkin announces first patient dosed in Phase 1 Clinical Trial of OKN4395, a first-in-class EP2/EP4/DP1 triple inhibitor for patients with solid tumors
January 30, 2025
Button
Owkin announces first patient dosed in Phase 1 Clinical Trial of OKN4395, a first-in-class EP2/EP4/DP1 triple inhibitor for patients with solid tumors
January 30, 2025
Button
Press release
Owkin announces Owkin K1.0 Turbigo, a cutting-edge operating system to create the first AGI for biology, at JP Morgan Healthcare Conference
January 13, 2025
Button
Owkin announces Owkin K1.0 Turbigo, a cutting-edge operating system to create the first AGI for biology, at JP Morgan Healthcare Conference
January 13, 2025
Button
Press release
Absci and Owkin synergize leading TechBio platforms to advance generative AI drug discovery
January 10, 2025
Button
Absci and Owkin synergize leading TechBio platforms to advance generative AI drug discovery
January 10, 2025
Button
Press release
Owkin unveils new insights into the opportunities and challenges for digital pathology and AI solutions in healthcare
December 12, 2024
Button
Owkin unveils new insights into the opportunities and challenges for digital pathology and AI solutions in healthcare
December 12, 2024
Button
Press release
Owkin and Proscia expand access to AI pre-screening for colorectal cancer patients
November 19, 2024
Button
Owkin and Proscia expand access to AI pre-screening for colorectal cancer patients
November 19, 2024
Button